Technosphere® insulin (Afrezza®; Mannkind Corporation, Danbury, CT, USA) is the only available inhaled insulin that has regulatory approval for the treatment of adult individuals with diabetes mellitus and has been available for more than a decade. This evidence concerns the gene INS and diabetes mellitus.